Evidence map›Paper›PMID 36605189›Full record

ArticleFrontiers in immunology2022

Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types.

Youngae Lee, Jang-Hee Oh, Na Li, Hyun-Jae Jang, Kyung-Seop Ahn, Sei-Ryang Oh, Dong Hun Lee, Jin Ho Chung

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Youngae LeeDepartment of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
Jang-Hee OhDepartment of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
Na LiDepartment of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
Hyun-Jae JangNatural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheong-ju, Chungcheongbuk-do, South Korea.
Kyung-Seop AhnNatural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheong-ju, Chungcheongbuk-do, South Korea.
Sei-Ryang OhNatural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheong-ju, Chungcheongbuk-do, South Korea.
Dong Hun LeeDepartment of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
Jin Ho ChungDepartment of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
Seoul National University · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skullcapflavone II (SFII), a flavonoid derived from

Indexed as

Anti-Inflammatory AgentsCytokinesDermatitis, AtopicFlavonoidsAnimalsHumansImmunoglobulin EMiceAnti-Inflammatory AgentsCytokinesFlavonoidsImmunoglobulin Eskullcapflavone IIatopic dermatitisIgEpruritusSkullcapflavone IITh2 cytokines

Identifiers

PMID36605189
PMCPMC9808403
OpenAlexW4313435263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.